Please login to the form below
Xencor’s Novartis-partnered bispecific on hold after patient deaths
The two death’s included one case of CRS
Big opportunities in big data, but EMA and industry just getting started
250m genomes sequenced, but data trapped in silos
Novartis’ Egatan gains US approval for neglected tropical disease
US approval removes barrier to greater access
Industry aghast as EU Parliament backs biosimilar rule change
The change could come into effect in 2021
Industry concerned about ‘rushed’ Brexit withdrawal legislation
The Patents Amendment could weaken the UK’s IP framework, warns biopharma
Finch’s microbiota drug for C. diff gets FDA breakthrough status
Boost for firm as it races rivals in microbiome space
No deal Brexit would see UK miss out on ‘safest medicines system in the world’
Health leaders say it would be 'a travesty'
NICE and Canadian counterpart to offer joint advice service
Agencies offer parallel scientific advice
Pfizer closes on EU approval of lung cancer drug Vizimpro
And AZ claims first with Forxiga in T1 diabetes
‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’
Brexit means pharma must review its intellectual property rights across Europe
-
Moving timesContinuity and stability are vital when it comes to the EMA's relocation when it leaves London
-
SMC gives green light for Amgen’s KyprolisThe committee also gives verdict on three other products
-
CAR-Ts go head-to-head after NICE clears Kymriah in DLBCLNovartis agrees pricing deal with NHS England
-
European Medicines Agency departs London ahead of BrexitRegulator moving to Amsterdam, as Novartis adds voice to no-deal warnings
-
Ministerial revolt looming over ‘no-deal’ Brexit riskAirbus CEO says no-deal Brexit could force it to relocate
-
Advaxis shaken by another FDA hold on cervical cancer vaccineSuspends enrolment into pivotal phase 3 trial
-
EMA says Lilly’s Lartruvo should not be prescribedFirst time EMA has acted on accelerated approval follow-up
-
UniQure cleared to start Huntington gene therapy trial
AMT-130 becomes the first AAV-based therapy approved for trials in Huntington’s disease
-
Vertex gains EU approval for earlier Orkambi useCystic Fibrosis drug approved in children aged 2-5 years
Latest regulatory appointments
-
Professor Carole Longson moves from NICE to the ABPIShe joins the UK pharma body as its chief scientific officer
-
MedTech Europe appoints new board of directors
Chair of the board Michelle Brennan is among those newly elected
-
Greg Perry joins IFPMA as assistant director generalWill move to the global industry body from the Medicines Patent Pool
-
AVEO appoints Nikhil Mehta as its senior VP, regulatory and quality assurance
He joins the biopharma from Tang Capital Management
-
IFPMA names new communications director
Helen Gallagher joins the association from Ferring Pharmaceuticals
Featured jobs
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Senior Medical Writer
-
Up to £50, 000 with Benefits
-
Senior Medical Writer
-
Salary TBC
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Account Director, Medical Education
-
Salary TBC
-
Senior Medical Writer
-
Great salary and benefits
-
Project Manager/ Account Manager
-
Salary TBC
-
Digital Account Director
-
Salary TBC
Subscribe to our email news alerts
- Drug launches to watch in 2019
- Immuno-oncology in 2019: the rapid evolution continues
- GW Pharma's cannabis-based medicine to be tested in dementia
- Novartis first to benefit from NICE advice on ‘patient preference’
- AZ says dropping MedImmune will help ‘streamline’ its R&D
- Merck puts prostate cancer firmly in Keytruda’s sights
- McCann Health's next challenge: creative differentiation
- Greater Manchester backs move to outcome-based payment
- Merck & Co to buy IO specialists Immune Design for $300m
- More good news, and some bad, for Merck’s Keytruda
- Xencor’s Novartis-partnered bispecific on hold after patient deaths
- Three billboards on the road to multichannel
PMHub
Life Healthcare Communications
Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...
Latest intelligence
- Three billboards on the road to multichannel
- Chris Ross examines the trends driving multichannel communication in 2019...
- How Medisafe is using AI to improve patient adherence
- Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
- Cell and gene therapy
- Tackling the manufacturing cost and complexity challenges...
Quick links
Infographics
